Siponimod Patent Expiration
Siponimod is Used for treating multiple sclerosis. It was first introduced by Novartis Pharmaceuticals Corp
Siponimod Patents
Given below is the list of patents protecting Siponimod, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Mayzent | US11944602 | Treatment of autoimmune disease in a patient receiving additionally a beta-blocker | Apr 23, 2036 | Novartis |
| Mayzent | US12533340 | Apr 23, 2036 | Novartis | |
| Mayzent | US12071402 | Immunosuppressant formulations | Jan 05, 2032 | Novartis |
| Mayzent | US8492441 | Dosage regimen of an S1P receptor agonist | Nov 30, 2030 | Novartis |
| Mayzent | US7939519 | Immunosuppresant compounds and compositions | Aug 27, 2028 | Novartis |
Siponimod's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List